UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 12/2005, Volume 353, Issue 25, pp. 2637 - 2639
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Asthma - mortality | Ethanolamines - adverse effects | Formoterol Fumarate | Salmeterol Xinafoate | United States | Humans | Albuterol - analogs & derivatives | United Kingdom | Clinical Trials as Topic | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Albuterol - therapeutic use | Ethanolamines - therapeutic use | Adrenergic beta-Agonists - therapeutic use | Drug Therapy, Combination | Adrenergic beta-Agonists - adverse effects | Albuterol - adverse effects | Complications and side effects | Public health advisory groups | Laws, regulations and rules | Risk factors | Salmeterol | Asthma | Confidence intervals | Hypotheses | Drug therapy | Patients | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 16, pp. 1592 - 1595
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Risk Assessment | United States | Humans | Administration, Inhalation | Drug Approval | Asthma - drug therapy | Advisory Committees | Drug Labeling | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Delayed-Action Preparations | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Complications and side effects | Usage | Salmeterol | Adrenergic beta agonists | Formoterol | Drug therapy, Combination | Drug therapy | Asthma | Pediatrics | Teenagers | Meetings | Committees | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 2004, Volume 125, Issue 6, pp. 2309 - 2321
Adrenergic β-agonists | Adverse effects | Cardiovascular | Asthma | COPD | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Asthma - diagnosis | Pulmonary Disease, Chronic Obstructive - mortality | Severity of Illness Index | Asthma - mortality | Pulmonary Disease, Chronic Obstructive - diagnosis | Drug Administration Schedule | Risk Assessment | Humans | Male | Survival Rate | Cardiovascular System - drug effects | Asthma - drug therapy | Randomized Controlled Trials as Topic | Dose-Response Relationship, Drug | Female | Adrenergic beta-Agonists - therapeutic use | Respiratory Function Tests | Adrenergic beta-Agonists - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 12/2002, Volume 110, Issue 6, pp. S322 - S328
Airway responsiveness | asthma mortality | cardiotoxicity | β-agonist | inflammation | Inflammation | Cardiotoxicity | Asthma mortality | Genotype | Clinical Trials as Topic | Pharmaceutical Preparations | Bronchodilator Agents - adverse effects | Humans | Adrenergic beta-Agonists - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 16, pp. 1671 - 1672
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Risk Assessment | Humans | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Asthma - drug therapy | Adrenergic beta-Agonists - adverse effects | Prevention | Adrenergic beta agonists | Complications and side effects | Drug therapy | Salmeterol | Asthma | Respiratory therapy | Clinical trials | Pediatrics | Meetings | Index Medicus | Abridged Index Medicus
Journal Article
Annals of allergy, asthma, & immunology, ISSN 1081-1206, 03/2020, Volume 124, Issue 3, pp. 254 - 260
Pulmonary and Respiratory Medicine | Immunology and Allergy | Immunology | Allergy | Life Sciences & Biomedicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Asthma - diagnosis | Severity of Illness Index | Follow-Up Studies | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Treatment Outcome | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Young Adult | Adrenal Cortex Hormones - adverse effects | Adolescent | Adrenergic beta-Agonists - administration & dosage | Biomarkers | Adult | Female | Adrenergic beta-Agonists - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Odds Ratio | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 06/2006, Volume 144, Issue 12, pp. 904 - 912
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Asthma - mortality | Recurrence | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Humans | Hospitalization - statistics & numerical data | Male | Ethanolamines - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Child | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Drug Administration Schedule | Risk Factors | Albuterol - analogs & derivatives | Treatment Outcome | Asthma - drug therapy | Randomized Controlled Trials as Topic | Anti-Asthmatic Agents - administration & dosage | Albuterol - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Cochrane database of systematic reviews, ISSN 1469-493X, 2009, Issue 3, pp. CD007949 - CD007949
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Beclomethasone - administration & dosage | Formoterol Fumarate | Salmeterol Xinafoate | Humans | Albuterol - analogs & derivatives | Male | Asthma - drug therapy | Ethanolamines - administration & dosage | Adrenal Cortex Hormones - adverse effects | Adolescent | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Beclomethasone - adverse effects | Female | Anti-Asthmatic Agents - administration & dosage | Drug Therapy, Combination | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage | Index Medicus
Journal Article
The American journal of medicine, ISSN 0002-9343, 2010, Volume 123, Issue 4, pp. 322 - 328.e2
Internal Medicine | Inhaled corticosteroids | Intubation | Long-acting beta-agonists | Mortality | Asthma | Meta-analysis | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Asthma - mortality | Humans | Administration, Inhalation | Male | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Adrenal Cortex Hormones - adverse effects | Asthma - complications | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Adrenergic beta-Agonists - therapeutic use | Intubation, Intratracheal | Odds Ratio | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage | Steroids | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 13, pp. 1169 - 1171
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Asthma - mortality | United States | Humans | Administration, Inhalation | Drug Approval | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Contraindications | Drug Labeling - legislation & jurisprudence | Adrenergic beta-Agonists - therapeutic use | Drug Therapy, Combination | Delayed-Action Preparations | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Adrenergic beta agonists | Complications and side effects | Reports | Usage | Drug therapy | Asthma | Studies | Confidence intervals | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 08/2009, Volume 136, Issue 2, pp. 604 - 607
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Asthma - mortality | United States | Humans | Male | Delayed-Action Preparations - administration & dosage | Dose-Response Relationship, Drug | Drug-Related Side Effects and Adverse Reactions | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Female | Drug Therapy, Combination | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Needs Assessment | Asthma - diagnosis | Severity of Illness Index | Salmeterol Xinafoate | Drug Administration Schedule | Risk Assessment | Administration, Inhalation | Albuterol - analogs & derivatives | Survival Rate | Asthma - drug therapy | Randomized Controlled Trials as Topic | Adrenal Cortex Hormones - adverse effects | Delayed-Action Preparations - adverse effects | Respiratory Function Tests | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory cell and molecular biology, ISSN 1044-1549, 09/2013, Volume 49, Issue 3, pp. 502 - 502
Respiratory System | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Ethanolamines - pharmacology | Animals | Asthma - chemically induced | Adrenergic beta-2 Receptor Agonists - pharmacology | Disease Models, Animal | Index Medicus | Correspondence
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 11/2008, Volume 178, Issue 10, pp. 1009 - 1016
Long-acting β-agonists | Systematic review | Adverse events | Randomized trials | Toxicity | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Drug Interactions | Humans | Administration, Inhalation | Adrenergic beta-Antagonists - adverse effects | Drug Therapy, Combination | Asthma - drug therapy | Adrenal Cortex Hormones - administration & dosage | Randomized Controlled Trials as Topic | Index Medicus | Abridged Index Medicus
Journal Article